Deals channel feed – Endpoints News

Deals channel feed

Daiichi and Zymeworks end antibody pact after seven years

3 years ago

Novartis and Biogen pull out of neuro drug partnerships with Sangamo

3 years ago

What kind of PhIIb data is worth $4B cash? Takeda’s Andy Plump has some thoughts on that

3 years ago

BeiGene decides not to license DKK1 drug, but keeps PD-1 combo trial in gastric cancer

3 years ago

Dr. Reddy’s divests $33M worth of dermatology brands in India

3 years ago

Seagen quietly doles out cell therapy patent rights, but scope remains unclear

3 years ago

Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK

3 years ago

Esperion stock halved after Daiichi discord over $440M heart pill milestones

3 years ago

Jounce faces hostile takeover bid from minority stakeholder

3 years ago

Novartis looks to offload even more of its eye products — report

3 years ago

Synaffix expands ADC deal from 2022 with MacroGenics

3 years ago

Bristol Myers passes on two Exscientia oncology candidates, but biotech to move them into clinic next year

3 years ago

Celltrion teams up with another Korean biopharma in antibody discovery deal

3 years ago

Updated: Pfizer to buy Seagen for $43B, ending long-running M&A saga for biotech

3 years ago

Sanofi to pay $2.9B for Provention Bio and its diabetes-delaying drug Tzield

3 years ago

Updated: Worries over Silicon Valley Bank ripple through tech and biotech startups, VCs

3 years ago

Ex-NIH, Sanofi leaders nab Merck support for their biotech’s Epstein-Barr vaccine

3 years ago

F-star's sale to Chinese buyer cleared by CFIUS following months of holdup

3 years ago

Chiesi puts down $200M+ to collaborate with Affibody for respiratory diseases

3 years ago

Oncology specialist Volastra brings in PhI drug from Amgen, nabs $60M in Series A

3 years ago

Months after reorg, Adaptimmune merges with fellow cell therapy developer

3 years ago

Voyager nabs $25M cash as Novartis runs with two AAV capsids for neuro gene therapy

3 years ago

Shanghai's Abbisko out-licenses EGFR candidate in potentially nine-figure deal

3 years ago

Dynacure to merge with Flamingo, rejoining two Ionis-affiliated biotechs

3 years ago

First page Previous page 40 41 424344 45 46 Next page Last page